These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7784077

  • 1. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ.
    Oncogene; 1995 Jun 15; 10(12):2289-96. PubMed ID: 7784077
    [Abstract] [Full Text] [Related]

  • 2. An essential role for Rac in Ras transformation.
    Qiu RG, Chen J, Kirn D, McCormick F, Symons M.
    Nature; 1995 Mar 30; 374(6521):457-9. PubMed ID: 7700355
    [Abstract] [Full Text] [Related]

  • 3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

  • 4. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M, Kishida S, Murai H, Hinoi T, Kikuchi A.
    Cancer Res; 1996 May 15; 56(10):2387-92. PubMed ID: 8625316
    [Abstract] [Full Text] [Related]

  • 5. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N, Crespo P, Bustelo XR.
    Oncogene; 1999 Oct 21; 18(43):5860-9. PubMed ID: 10557073
    [Abstract] [Full Text] [Related]

  • 6. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM, Pegg AE.
    Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886
    [Abstract] [Full Text] [Related]

  • 7. Rac1 and extracellularly regulated kinase activation are sufficient for E1A-dependent cooperative transformation of primary epithelial cells, but progression can only be modulated by E1A or Rac1.
    Fischer RS, Zheng Y, Quinlan MP.
    Cell Growth Differ; 1998 Mar 01; 9(3):209-21. PubMed ID: 9543387
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
    Izawa I, Amano M, Chihara K, Yamamoto T, Kaibuchi K.
    Oncogene; 1998 Dec 03; 17(22):2863-71. PubMed ID: 9879992
    [Abstract] [Full Text] [Related]

  • 9. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M, Teramoto H, Katz BZ, Yamada KM, Gutkind JS.
    Oncogene; 1998 Aug 27; 17(8):991-8. PubMed ID: 9747878
    [Abstract] [Full Text] [Related]

  • 10. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA, Solski PA, Jillian SA, Pérez de la Ossa P, D'Eustachio P, Der CJ, Rush MG.
    Oncogene; 1999 Jul 01; 18(26):3831-45. PubMed ID: 10445846
    [Abstract] [Full Text] [Related]

  • 11. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
    Heinicke T, Radziwill G, Nawrath M, Rommel C, Pavlovic J, Moelling K.
    Cancer Gene Ther; 2000 May 01; 7(5):697-706. PubMed ID: 10830717
    [Abstract] [Full Text] [Related]

  • 12. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, Der CJ.
    Oncogene; 1998 Sep 17; 17(11 Reviews):1415-38. PubMed ID: 9779988
    [Abstract] [Full Text] [Related]

  • 13. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E.
    Oncogene; 1998 Feb 05; 16(5):613-24. PubMed ID: 9482107
    [Abstract] [Full Text] [Related]

  • 14. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y, Gutierrez L, Wrathall LS, Lu YY, Blair DG, Clanton DJ, Hwang YW, Shih TY.
    Cell Growth Differ; 1990 May 05; 1(5):217-24. PubMed ID: 2150753
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway.
    Perletti GP, Concari P, Brusaferri S, Marras E, Piccinini F, Tashjian AH.
    Oncogene; 1998 Jun 25; 16(25):3345-8. PubMed ID: 9681835
    [Abstract] [Full Text] [Related]

  • 16. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
    Ulkü AS, Schäfer R, Der CJ.
    Mol Cancer Res; 2003 Dec 25; 1(14):1077-88. PubMed ID: 14707291
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH.
    Oncogene; 1996 Feb 15; 12(4):775-84. PubMed ID: 8632899
    [Abstract] [Full Text] [Related]

  • 18. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
    Cox AD, Brtva TR, Lowe DG, Der CJ.
    Oncogene; 1994 Nov 15; 9(11):3281-8. PubMed ID: 7936652
    [Abstract] [Full Text] [Related]

  • 19. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
    Shah V, Bharadwaj S, Kaibuchi K, Prasad GL.
    Oncogene; 2001 Apr 19; 20(17):2112-21. PubMed ID: 11360195
    [Abstract] [Full Text] [Related]

  • 20. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
    Saez R, Chan AM, Miki T, Aaronson SA.
    Oncogene; 1994 Oct 19; 9(10):2977-82. PubMed ID: 8084601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.